Bifunctional Polymeric Inhibitors of Human Influenza A Viruses

Purpose: New antiviral agents were prepared by attaching derivatives of sialic acid (1) and of the drug zanamivir (2) to poly(isobutylene-alt-maleic anhydride) (poly-(1 + 2)) or by mixing poly-1 and poly-2, followed by assaying them against wild-type and drug-resistant influenza A Wuhan viruses....

Full description

Bibliographic Details
Main Authors: Haldar, Jayanta, Alvarez de Cienfuegos, Luis, Tumpey, Terrence M., Gubareva, Larisa V., Chen, Jianzhu, Klibanov, Alexander M.
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Language:en_US
Published: Springer Science + Business Media B.V. 2012
Online Access:http://hdl.handle.net/1721.1/73085
https://orcid.org/0000-0003-3830-714X
https://orcid.org/0000-0002-5687-6154
_version_ 1826217968772579328
author Haldar, Jayanta
Alvarez de Cienfuegos, Luis
Tumpey, Terrence M.
Gubareva, Larisa V.
Chen, Jianzhu
Klibanov, Alexander M.
author2 Massachusetts Institute of Technology. Department of Biological Engineering
author_facet Massachusetts Institute of Technology. Department of Biological Engineering
Haldar, Jayanta
Alvarez de Cienfuegos, Luis
Tumpey, Terrence M.
Gubareva, Larisa V.
Chen, Jianzhu
Klibanov, Alexander M.
author_sort Haldar, Jayanta
collection MIT
description Purpose: New antiviral agents were prepared by attaching derivatives of sialic acid (1) and of the drug zanamivir (2) to poly(isobutylene-alt-maleic anhydride) (poly-(1 + 2)) or by mixing poly-1 and poly-2, followed by assaying them against wild-type and drug-resistant influenza A Wuhan viruses. Methods: Individually or together, 1 and 2 were covalently bonded to the polymer. The antiviral potencies of the resultant poly-1, poly-2, poly-(1 + 2), and poly-1 + poly-2, as well as 1 and 2, were assessed using plaque reduction assay. Results: Attaching 1 to the polymer improved at best millimolar IC50 values over three orders of magnitude. While 2 exhibited micromolar IC50 values, poly-2 was >100-fold even more potent. The IC50 of poly-(1 + 2) against the wild-type strain was >300-fold and ∼17-fold better than of poly-1 and poly-2, respectively. In contrast, the potency of poly-(1 + 2) vs. poly-2 against the mutant strain merely doubled. The mixture of poly-1 + poly-2 inhibited both viral strains similarly to poly-2. Conclusions: The bifunctional poly-(1 + 2) acts synergistically against the wild-type influenza virus, but not against its drug-resistant mutant, as compared to a physical mixture of the monofunctional poly-1 and poly-2.
first_indexed 2024-09-23T17:11:34Z
format Article
id mit-1721.1/73085
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T17:11:34Z
publishDate 2012
publisher Springer Science + Business Media B.V.
record_format dspace
spelling mit-1721.1/730852022-09-30T00:20:22Z Bifunctional Polymeric Inhibitors of Human Influenza A Viruses Haldar, Jayanta Alvarez de Cienfuegos, Luis Tumpey, Terrence M. Gubareva, Larisa V. Chen, Jianzhu Klibanov, Alexander M. Massachusetts Institute of Technology. Department of Biological Engineering Massachusetts Institute of Technology. Department of Biology Massachusetts Institute of Technology. Department of Chemistry Koch Institute for Integrative Cancer Research at MIT Klibanov, Alexander M. Alvarez de Cienfuegos, Luis Chen, Jianzhu Purpose: New antiviral agents were prepared by attaching derivatives of sialic acid (1) and of the drug zanamivir (2) to poly(isobutylene-alt-maleic anhydride) (poly-(1 + 2)) or by mixing poly-1 and poly-2, followed by assaying them against wild-type and drug-resistant influenza A Wuhan viruses. Methods: Individually or together, 1 and 2 were covalently bonded to the polymer. The antiviral potencies of the resultant poly-1, poly-2, poly-(1 + 2), and poly-1 + poly-2, as well as 1 and 2, were assessed using plaque reduction assay. Results: Attaching 1 to the polymer improved at best millimolar IC50 values over three orders of magnitude. While 2 exhibited micromolar IC50 values, poly-2 was >100-fold even more potent. The IC50 of poly-(1 + 2) against the wild-type strain was >300-fold and ∼17-fold better than of poly-1 and poly-2, respectively. In contrast, the potency of poly-(1 + 2) vs. poly-2 against the mutant strain merely doubled. The mixture of poly-1 + poly-2 inhibited both viral strains similarly to poly-2. Conclusions: The bifunctional poly-(1 + 2) acts synergistically against the wild-type influenza virus, but not against its drug-resistant mutant, as compared to a physical mixture of the monofunctional poly-1 and poly-2. National Institutes of Health (U.S.) (NIH grant U01-AI074443) Fundación Ramón Areces (postdoctoral fellowship) 2012-09-20T19:24:03Z 2012-09-20T19:24:03Z 2010-02 2009-09 Article http://purl.org/eprint/type/JournalArticle 0724-8741 1573-904X http://hdl.handle.net/1721.1/73085 Haldar, Jayanta et al. “Bifunctional Polymeric Inhibitors of Human Influenza A Viruses.” Pharmaceutical Research 27.2 (2009): 259–263. Web. https://orcid.org/0000-0003-3830-714X https://orcid.org/0000-0002-5687-6154 en_US http://dx.doi.org/10.1007/s11095-009-0013-1 Pharmaceutical Research Creative Commons Attribution-Noncommercial-Share Alike 3.0 http://creativecommons.org/licenses/by-nc-sa/3.0/ application/pdf Springer Science + Business Media B.V. PMC
spellingShingle Haldar, Jayanta
Alvarez de Cienfuegos, Luis
Tumpey, Terrence M.
Gubareva, Larisa V.
Chen, Jianzhu
Klibanov, Alexander M.
Bifunctional Polymeric Inhibitors of Human Influenza A Viruses
title Bifunctional Polymeric Inhibitors of Human Influenza A Viruses
title_full Bifunctional Polymeric Inhibitors of Human Influenza A Viruses
title_fullStr Bifunctional Polymeric Inhibitors of Human Influenza A Viruses
title_full_unstemmed Bifunctional Polymeric Inhibitors of Human Influenza A Viruses
title_short Bifunctional Polymeric Inhibitors of Human Influenza A Viruses
title_sort bifunctional polymeric inhibitors of human influenza a viruses
url http://hdl.handle.net/1721.1/73085
https://orcid.org/0000-0003-3830-714X
https://orcid.org/0000-0002-5687-6154
work_keys_str_mv AT haldarjayanta bifunctionalpolymericinhibitorsofhumaninfluenzaaviruses
AT alvarezdecienfuegosluis bifunctionalpolymericinhibitorsofhumaninfluenzaaviruses
AT tumpeyterrencem bifunctionalpolymericinhibitorsofhumaninfluenzaaviruses
AT gubarevalarisav bifunctionalpolymericinhibitorsofhumaninfluenzaaviruses
AT chenjianzhu bifunctionalpolymericinhibitorsofhumaninfluenzaaviruses
AT klibanovalexanderm bifunctionalpolymericinhibitorsofhumaninfluenzaaviruses